SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation.

Cancer Research
Martin K ThomsenTransatlantic Prostate Group

Abstract

Dysregulation of tissue development pathways can contribute to cancer initiation and progression. In murine embryonic prostate epithelia, the transcription factor SOX9 is required for proper prostate development. In this study, we examined a role for SOX9 in prostate cancer in mouse and human. In Pten and Nkx3.1 mutant mice, cells with increased levels of SOX9 appeared within prostate epithelia at early stages of neoplasia, and higher expression correlated with progression at all stages of disease. In transgenic mice, SOX9 overexpression in prostate epithelia increased cell proliferation without inducing hyperplasia. In transgenic mice that were also heterozygous for mutant Pten, SOX9 overexpression quickened the induction of high-grade prostate intraepithelial neoplasia. In contrast, Sox9 attenuation led to a decrease proliferating prostate epithelia cells in normal and homozygous Pten mutant mice with prostate neoplasia. Analysis of a cohort of 880 human prostate cancer samples showed that SOX9 expression was associated with increasing Gleason grades and higher Ki67 staining. Our findings identify SOX9 as part of a developmental pathway that is reactivated in prostate neoplasia where it promotes tumor cell proliferation.

References

Aug 11, 1998·Nature Genetics·A Di CristofanoP P Pandolfi
Feb 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·K PodsypaninaR Parsons
Apr 24, 1999·Genes & Development·R Bhatia-GaurM M Shen
May 13, 1999·Nature Genetics·W BiB de Crombrugghe
Feb 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Minjung J KimCory Abate-Shen
Feb 22, 2002·Genesis : the Journal of Genetics and Development·Ralf LescheHong Wu
Jun 26, 2002·The Journal of Cell Biology·Akira TsujimuraE Lynette Wilson
Aug 7, 2002·The American Journal of Pathology·Jae-Hak ParkRobert D Cardiff
Oct 3, 2003·Development·Martin Cheung, James Briscoe
Jan 25, 2006·Proceedings of the National Academy of Sciences of the United States of America·Shunyou WangHong Wu
Feb 10, 2006·Annals of the New York Academy of Sciences·Akio KobayashiRichard R Behringer
Nov 2, 2006·British Journal of Cancer·J CuzickUNKNOWN Transatlantic Prostate Group
Jan 24, 2007·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Jul 20, 2007·Oncogene·G AttardUNKNOWN Transatlantic Prostate Group
Mar 8, 2008·Developmental Biology·Martin K ThomsenAmanda Swain
Jun 19, 2008·Differentiation; Research in Biological Diversity·Martin K ThomsenAmanda Swain
Oct 24, 2008·Nature·Kevin G LeongWei-Qiang Gao
Nov 21, 2008·American Journal of Clinical Pathology·Bingjian LüMaode Lai
Mar 11, 2009·The Journal of Clinical Investigation·Thierry PasseronVincent J Hearing
Jan 22, 2013·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal

❮ Previous
Next ❯

Citations

Jun 21, 2012·Medical Oncology·Liang WangYongsheng Zhang
Jan 17, 2012·Cancer Research·Ander MatheuRobin Lovell-Badge
Apr 15, 2011·The Journal of Clinical Investigation·Eugenia C Pacheco-PinedoEdward E Morrisey
Feb 22, 2013·The Journal of Clinical Investigation·Changmeng CaiXin Yuan
Mar 6, 2012·Journal of Experimental & Clinical Cancer Research : CR·Chun-Hui ZhouLi-Yun Gong
Apr 18, 2013·PloS One·Stella KoutrosLaura E Beane Freeman
Jul 31, 2013·Oncogene·S MurakamiF Tashiro
Apr 25, 2014·Asian Journal of Andrology·Steven P Balk
Jan 16, 2014·Cancer Metastasis Reviews·Michael A AugelloKaren E Knudsen
Sep 30, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Kasomva KhanmiMichael Gabriel Paulraj
Jun 2, 2015·Expert Opinion on Drug Discovery·Kenneth C Valkenburg, Kenneth J Pienta
Jan 18, 2011·Trends in Molecular Medicine·James PritchettKaren Piper Hanley
Apr 5, 2016·The Journal of Clinical Investigation·Fen MaXin Yuan
Feb 27, 2015·Cell Biochemistry and Biophysics·Hongwei LiuJingchen Lu
Jul 28, 2012·Expert Opinion on Therapeutic Targets·Sandra D Castillo, Montse Sanchez-Cespedes
Jun 23, 2015·Cell Stem Cell·Jean-Christophe LarsimontCédric Blanpain
Feb 17, 2015·Genes & Diseases·Alice JoRex C Haydon
Dec 20, 2014·Cell Death and Differentiation·M K ThomsenE F Wagner
Dec 31, 2014·Current Problems in Cancer·Fei LianCarlos S Moreno
Aug 1, 2016·Seminars in Cell & Developmental Biology·Ya-Ru Xu, Wan-Xi Yang
Oct 14, 2016·FEBS Letters·Xiyao LiuShizhong Zhang
Nov 25, 2016·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Monica Montano, Wade Bushman
Jan 1, 2011·Cancers·Mukesh VermaMudit Verma
Jul 12, 2013·Clinical Medicine Insights. Oncology·Kazushi InouePankaj Taneja
Dec 13, 2017·Cold Spring Harbor Perspectives in Medicine·Jeffrey C Francis, Amanda Swain
Apr 18, 2018·Cold Spring Harbor Perspectives in Medicine·Juan M Arriaga, Cory Abate-Shen
Feb 15, 2012·Virchows Archiv : an International Journal of Pathology·Minhua SunMasashi Fukayama
Aug 15, 2014·International Journal of Oncology·Paul Toren, Amina Zoubeidi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.